James Altunkaya
Colleges
James Altunkaya
NIHR Doctoral Research Fellow
James is a NIHR Doctoral Research Fellow in the Health Economics Research Centre (HERC) at Oxford Population Health. He aims to provide economic evidence regarding the role of precision medicine in prediabetes.
For his DPhil, he is building and validating a new economic model of prediabetes and its consequences. This combines data from several clinical trials and cohort studies to predict individual patients’ long-term health outcomes and costs. This will allow s to understand the cost-effectiveness of early precision interventions targeted to specific prediabetes patients.
He has joined HERC in 2019 as a researcher in health economics, and prior to this held a NIHR Research Methods Fellowship at the Centre for Health Economics at the University of York. There, he was a member of the NICE academic evidence review group, critiquing the economic case for introducing new pharmaceuticals and medical devices into the NHS.
He holds a MSc in Public Health (Health Economics) from the London School of Hygiene and Tropical Medicine, and a BA in Philosophy, Politics and Economics from the University of Oxford.
Recent publications
-
The Impact of Unrelated Future Medical Costs on Economic Evaluation Outcomes for Different Models of Diabetes.
Journal article
Zhao T. et al, (2024), Appl Health Econ Health Policy
-
Examining the impact of structural uncertainty across ten type 2 diabetes models: Results from the 2022 Mount Hood Challenge.
Journal article
Altunkaya J. et al, (2024), Value Health
-
Associations between body mass index and hospital resource use in patients hospitalised for COVID-19 in England: A community-based cohort study
Journal article
Altunkaya J. et al, (2024), The Lancet Diabetes and Endocrinology
-
Potential Value of Identifying Type 2 Diabetes Subgroups for Guiding Intensive Treatment: A Comparison of Novel Data-Driven Clustering With Risk-Driven Subgroups.
Journal article
Li X. et al, (2023), Diabetes Care
-
Estimating the Economic Value of Automated Virtual Reality Cognitive Therapy for Treating Agoraphobic Avoidance in Patients With Psychosis: Findings From the gameChange Randomized Controlled Clinical Trial.
Journal article
Altunkaya J. et al, (2022), Journal of medical Internet research, 24